Two directors of Square Pharmaceuticals have completed share purchases worth Tk 64.58 crore, according to disclosures posted on the Dhaka Stock Exchange (DSE) today.

Samuel S Chowdhury, a director of the company, has bought 15 lakh shares from the market in line with an earlier declaration made on March 10. 

Based on Thursday's closing price of Tk 215.40 per share, the purchase would be valued at Tk 32.29 crore.

In a separate disclosure, Ratna Patra, another director, also bought 15 lakh shares following her declaration dated March 12. 

Her transaction, too, would amount to Tk 32.29 crore based on the same closing price.

Shares of Square Pharma edged up 0.05 percent to Tk 215.40 during morning trading at the DSE today.

The company's sponsor-directors jointly hold 43.44 percent of its shares as of March 31, 2025, DSE data shows. Institutional investors hold 13.76 percent, foreign investors 15.35 percent, and the general public 27.45 percent.

Square Pharmaceuticals, established in 1958 and listed on the stock exchanges in 1995, is the country's largest drugmaker. The company has retained its leadership position in the pharmaceutical sector since 1985, according to its website.

With a growing footprint in both domestic and international markets, Square continues to be a major contributor to the country's pharmaceutical exports and healthcare supply chain.